EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Hospitalization Trends and Risk Factors in Rheumatoid Arthritis-Related Interstitial Lung Disease

Lee M Fidler, Joseph S Munn, Jolene H Fisher, Shane Shapera, Andrea S Gershon

CHEST · 2025-11 · 168 (5) · 1162-1172

DOI: 10.1016/j.chest.2025.05.030 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift CHEST, 2025-11. Verfasst von Lee M Fidler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Division of Respirology, Department of Medic…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Arthritis, Rheumatoid, Hospitalization. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Institut canadien d'information sur la santé, Canadian Pulmonary Fibrosis Foundation, University of Toronto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Rheumatoid arthritis (RA)-related interstitial lung disease (ILD) represents an important disease manifestation of rheumatoid arthritis. A scarcity of population-level information on hospitalization rates in RA-ILD exists. RESEARCH QUESTION: What are the current rates of ILD-related hospitalizations in patients with RA-ILD? STUDY DESIGN AND METHODS: We performed a retrospective observational study using health services data from Ontario, Canada, between 2003 and 2022. We identified people with RA-ILD using the Ontario Rheumatoid Arthritis Database and required repeated physician claims for ILD before cohort entry. We estimated age- and sex-standardized annual RA-ILD-related hospitalization rates during the study period. We performed multivariable logistic regression to ascertain factors associated with an RA-ILD diagnosis during a hospitalization and generated a Fine-Gray subdistribution hazards model with competing risk to assess the time to RA-ILD-related hospitalization. RESULTS: We identified 7,075 people with RA-ILD during the cohort period. Standardized RA-ILD-related hospitalizations increased from 2.6 to 3.5 admissions per 100,000 people (37% increase; P = .045). In-hospital mortality from RA-ILD-related admissions was 19.5 deaths per 100 admissions in 2022, having remained stable over time (P = .62). Patients in the lowest income quintile (OR, 1.35 [95% CI, 1.06-1.72]; P = .02) and residing in rural areas (OR, 1.37 [95% CI, 1.11-1.70]; P = .004) were more likely to receive a diagnosis of RA-ILD during a hospitalization. Patients diagnosed with RA-ILD during a hospitalization had an increased hazard for future RA-ILD-related admissions (hazard ratio, 1.44 [95% CI,1.24-1.68]; P < .001). INTERPRETATION: The results of this study show that RA-ILD-related hospitalizations are increasing. In-hospital mortality has not changed over time, but remains substantial. Socioeconomic factors were shown to be associated with receiving an RA-ILD diagnosis in the hospital, which appears to be an important risk factor for future RA-ILD-related admissions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialArthritis, RheumatoidHospitalizationHumansFemaleOntarioMaleRisk FactorsRetrospective StudiesAgedMiddle AgedHospital Mortality

Stichwörter der Autor:innen

hospitalizationsinterstitial lung diseaserheumatoid arthritis

Autor:innen und Institutionen

  • Division of Respirology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Respirolo…
  • ICES, Toronto, ON, Canada; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Division of Respirology, Department of Medicine, University Health Network, Toronto, ON, Canada.
  • Division of Respirology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Ca…

Förderung

  • Institut canadien d'information sur la santé
  • Canadian Pulmonary Fibrosis Foundation
  • University of Toronto
  • Ontario Ministry of Health and Long-Term Care
  • Institute for Clinical Evaluative Sciences
  • National Institutes of Health

Zitieren

APA

Fidler, L. M., Munn, J. S., Fisher, J. H., Shapera, S., & Gershon, A. S. (2025). Hospitalization Trends and Risk Factors in Rheumatoid Arthritis-Related Interstitial Lung Disease. CHEST, 168(5), 1162-1172. https://doi.org/10.1016/j.chest.2025.05.030

Vancouver

Fidler LM, Munn JS, Fisher JH, Shapera S, Gershon AS. Hospitalization Trends and Risk Factors in Rheumatoid Arthritis-Related Interstitial Lung Disease. CHEST. 2025;168(5):1162-1172. doi:10.1016/j.chest.2025.05.030

BibTeX
@article{Fidler2025,
  author = {Fidler, Lee M and Munn, Joseph S and Fisher, Jolene H and Shapera, Shane and Gershon, Andrea S},
  title = {Hospitalization Trends and Risk Factors in Rheumatoid Arthritis-Related Interstitial Lung Disease},
  journal = {CHEST},
  year = {2025},
  volume = {168},
  number = {5},
  pages = {1162--1172},
  doi = {10.1016/j.chest.2025.05.030}
}
Kostenlos starten →